共有 16 笔近期内部人交易记录记录，涉及 Upstream Bio, Inc. (UPB), 包括 11 笔买入 和 5 笔卖出. 内部人买入总额为 $1.19M 内部人卖出总额为 $46.57K.
近期活跃的重要内部人包括 Gray Michael, Sutherland Everett Rand, Houghton Adam. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — UPB
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-16 |
Gray Michael |
CFO and COO |
知情卖出 |
852 |
$9.29 |
$7.92K |
29,648 |
| 2026-03-16 |
Sutherland Everett Rand |
Chief Executive Officer |
知情卖出 |
2,093 |
$9.29 |
$19.44K |
72,907 |
| 2026-03-16 |
Houghton Adam |
Chief Business Officer |
知情卖出 |
699 |
$9.29 |
$6.49K |
24,301 |
| 2026-03-16 |
Deykin Aaron |
Chief Medical Officer |
知情卖出 |
894 |
$9.29 |
$8.31K |
32,687 |
| 2026-03-16 |
Ambrose Allison |
General Counsel |
知情卖出 |
475 |
$9.29 |
$4.41K |
16,525 |
| 2026-01-02 |
Gray Michael |
CFO and COO |
限制性股票授予 (RSU) |
30,500 |
- |
- |
30,500 |
| 2026-01-02 |
Sutherland Everett Rand |
Chief Executive Officer |
限制性股票授予 (RSU) |
75,000 |
- |
- |
75,000 |
| 2026-01-02 |
Houghton Adam |
Chief Business Officer |
限制性股票授予 (RSU) |
25,000 |
- |
- |
25,000 |
| 2026-01-02 |
Deykin Aaron |
Chief Medical Officer |
限制性股票授予 (RSU) |
32,000 |
- |
- |
33,581 |
| 2026-01-02 |
Ambrose Allison |
General Counsel |
限制性股票授予 (RSU) |
17,000 |
- |
- |
17,000 |
| 2025-06-10 |
Renaud Ronald C Jr |
Director |
限制性股票授予 (RSU) |
17,096 |
$11.59 |
$198.14K |
17,096 |
| 2025-06-10 |
Beckman Daniella |
Director |
限制性股票授予 (RSU) |
17,096 |
$11.59 |
$198.14K |
17,096 |
| 2025-06-10 |
Ratcliffe Liam |
Director |
限制性股票授予 (RSU) |
17,096 |
$11.59 |
$198.14K |
17,096 |
| 2025-06-10 |
Chimovits Erez |
Director |
限制性股票授予 (RSU) |
17,096 |
$11.59 |
$198.14K |
17,096 |
| 2025-06-10 |
Fleming Harold Edward |
Director |
限制性股票授予 (RSU) |
17,096 |
$11.59 |
$198.14K |
17,096 |
| 2025-06-10 |
Ruddy Marcella K. |
Director |
限制性股票授予 (RSU) |
17,096 |
$11.59 |
$198.14K |
17,096 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
